Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.465 AUD 4.49% Market Closed
Market Cap: 852.2m AUD

Intrinsic Value

The intrinsic value of one BOT stock under the Base Case scenario is 1.861 AUD. Compared to the current market price of 0.465 AUD, Botanix Pharmaceuticals Ltd is Undervalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BOT Intrinsic Value
1.861 AUD
Undervaluation 75%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Botanix Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BOT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BOT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Botanix Pharmaceuticals Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Botanix Pharmaceuticals Ltd’s research
View All Researches
Botanix Pharmaceuticals Ltd
ASX:BOT
AU
Pharmaceuticals
Market Cap
845.2m AUD
IPO
Jan 24, 1985
AU
Pharmaceuticals
Market Cap
845.2m AUD
IPO
Jan 24, 1985
Price
AU$false
EPS
AU$false
AI Assistant
AI Assistant
Ask me anything about Botanix Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Botanix Pharmaceuticals Ltd

Current Assets 67.8m
Cash & Short-Term Investments 48.4m
Receivables 799.5k
Other Current Assets 18.6m
Non-Current Assets 31.7m
PP&E 925.7k
Intangibles 30.7m
Efficiency

Free Cash Flow Analysis
Botanix Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Botanix Pharmaceuticals Ltd

Revenue
569.6k AUD
Cost of Revenue
-1.3m AUD
Gross Profit
-724.9k AUD
Operating Expenses
-39.7m AUD
Operating Income
-40.4m AUD
Other Expenses
1.1m AUD
Net Income
-39.3m AUD
Fundamental Scores

BOT Profitability Score
Profitability Due Diligence

Botanix Pharmaceuticals Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 1-Year Revenue Growth
26/100
Profitability
Score

Botanix Pharmaceuticals Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

BOT Solvency Score
Solvency Due Diligence

Botanix Pharmaceuticals Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Botanix Pharmaceuticals Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.663 AUD with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.

Lowest
Price Target
0.657 AUD
41% Upside
Average
Price Target
0.663 AUD
43% Upside
Highest
Price Target
0.683 AUD
47% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BOT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BOT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BOT stock?

The intrinsic value of one BOT stock under the Base Case scenario is 1.861 AUD.

Is BOT stock undervalued or overvalued?

Compared to the current market price of 0.465 AUD, Botanix Pharmaceuticals Ltd is Undervalued by 75%.

Back to Top